OBJECTIVE: To increase awareness of unusual inflammatory and other responses including severe insulin resistance (IR) associated with the use of targeted immunotherapies such as brentuximab. METHODS: We report the case of a man without any previous diagnosis of diabetes who developed diabetic ketoacidosis complicated by severe IR (unresponsive to >600 units of intravenous insulin per hour) after receiving brentuximab for Hodgkin lymphoma. RESULTS: Autoantibodies to the insulin receptor were not detected in the patient's serum, thus excluding a diagnosis of type B IR. CONCLUSION: We hypothesize that brentuximab administration led to a rare reaction leading to systemic cytokine release with extreme IR in our patient.
OBJECTIVE: To increase awareness of unusual inflammatory and other responses including severe insulin resistance (IR) associated with the use of targeted immunotherapies such as brentuximab. METHODS: We report the case of a man without any previous diagnosis of diabetes who developed diabetic ketoacidosis complicated by severe IR (unresponsive to >600 units of intravenous insulin per hour) after receiving brentuximab for Hodgkin lymphoma. RESULTS: Autoantibodies to the insulin receptor were not detected in the patient's serum, thus excluding a diagnosis of type B IR. CONCLUSION: We hypothesize that brentuximab administration led to a rare reaction leading to systemic cytokine release with extreme IR in our patient.
Authors: Robert Zeiser; Vu H Nguyen; Jing-Zhou Hou; Andreas Beilhack; Elizabeth Zambricki; Martin Buess; Christopher H Contag; Robert S Negrin Journal: Blood Date: 2006-10-26 Impact factor: 22.113
Authors: Maria Ilaria Del Principe; Giuseppe Sconocchia; Francesco Buccisano; Mariagiovanna Cefalo; Ambra Di Veroli; Giovanna De Santis; Daniela Nasso; Luca Maurillo; Lucia Anemona; Massimiliano Postorino; Giovanni Del Poeta; Sergio Amadori; Adriano Venditti Journal: Ann Hematol Date: 2014-07-02 Impact factor: 3.673
Authors: Stefan K Alig; Martin Dreyling; Bettina Seppi; Benedikt Aulinger; Lukas Witkowski; Christina T Rieger Journal: Eur J Haematol Date: 2014-07-02 Impact factor: 2.997
Authors: Kenneth R Carson; Scott D Newsome; Ellen J Kim; Nina D Wagner-Johnston; Gloria von Geldern; Craig H Moskowitz; Alison J Moskowitz; Alain H Rook; Pankaj Jalan; Alison W Loren; Daniel Landsburg; Thomas Coyne; Donald Tsai; Dennis W Raisch; LeAnn B Norris; P Brandon Bookstaver; Oliver Sartor; Charles L Bennett Journal: Cancer Date: 2014-04-25 Impact factor: 6.860